Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck

Clinical Cancer Research

Volumn 4, Issue 10, 1998, Pages 2411-2418

  Matthias, Christoph ^a   Branigan, Kate ^c   Jahnke, Volker ^a   Leder, Korinna ^a   Haas, Judith ^a   Heighway, Jim ^b   Jones, Peter W ^c   Strange, Richard C ^c   Fryer, Anthony A ^c   Hoban, Paul R ^c,d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL CYCLE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, GENETIC; PROGNOSIS;

EID: 0031754975     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Johnson, N. W., Ranasinghe, A. W., and Warnakulasuriya, K. A. A. S. Potentially malignant lesions and conditions of the mouth and oropharynx: natural history - cellular and molecular markers of risk. Eur. J. Cancer Prev., 2: 31-51, 1993.
2. Jahnke, V. Bösartige tumouren des larynx. In: H. H. Nauman, J. Helms, C. Herberhold, and E. Kastenbauer (eds.), Oto-Rhino-Laryngologie in Klinik und Praxis, Vol. 3, pp. 388-421. Stuttgart-New York: Georg Thieme Verlag, 1995.
3. Muir, C., and Weiland, L. Upper aerodigestive tract cancers. Cancer (Phila.), 75: 147-153, 1995.
4. Copper, M. P., Jovanovic, A., Nauta, J. J. P., Braakhuis, B. J. M., Vries, N., Waal, I., and Snow, G. B. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch. Otolaryngol., 121: 157-160, 1995.
5. Matthias, C., Bockmühl, U., Jahnke, V., Jones, P. W., Hayes, J., Alldersea, J., Gilford, J., Bailey, L., Bath, J., Worrall, S. F., Hand, P., Fryer, A. A., and Strange, R. C. Polymorphism in cytochrome-P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics, 8: 91-100, 1998.
6. Janot, F., Klijanienko, J., Russo, A., Mamet, J. P., de Braud, F., El-Naggar, A. K., Pignon, J. P., Luboinski, B., and Cvitkovic, E. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br. J. Cancer, 73: 531-538, 1996.
7. Magnano, M., Bussi, M., de Stefani, A., Milan, F., Lerda, W., Ferrero, V., Gervasio, F., Ragona, R., Gabriele, P., Valente, G., and Cortesina, G. Prognostic factors for head and neck tumour recurrence. Acta Otolaryngol., 115: 833-838, 1995.
8. Park, J. Y., Muscat, J. E., Ren, Q., Schantz, S. P., Harwick, R. D., Stern, J. C., Pike, V., Richie, J. P., Jr., and Lazarus, P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol. Biomark. Prev., 6: 791-797, 1997.
9. Jourenkova, N., Reinikainen, M., Bouchardy, C., Dayer, P., Benhamhou, S., and Hirvonen, A. Larynx cancer risk in relation to glutathione-S transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol. Biomark. Prev., 7: 19-23 1998.
10. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
11. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
12. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M., and Arnold, A. A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature (Lond.), 350: 512-515, 1991.
13. de Boer, C. J., Loyson, S., Kluin, P. M., Kluion-Neleman, H. C., Schuuring, E., and van Krieken, J. H. J. M. Multiple breakpoints with the bcl-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Res., 53: 4148-4152, 1993.
14. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M. A., Villamor, N., Tassies, D., Jaffe, E. S., Montserrate, E., Rozman, C., and Cardesa, A. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliterative disorders: a highly specific marker in mantle cell lymphoma. Blood, 84: 2726-2732, 1994.
15. Callender, T., El-Naggar, A. K., Lee, M. S., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD-1 (CCND1)/Cyclin D1 oncogene amplification in head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
16. Jares, P., Fernandez, P. L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Bosch, F., Aiza, G., Nayach, I., Trassera, J., and Cardesa, A. PRAD-1/Cyclin D1 gene amplification correlates with messenger mRNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
17. Gillet, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
18. Betticher, D., Heighway, J., Haselton, P. S., Altermatt, M. J., Ryder W. D. J., Cerny T., and Thatcher, N. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br. J. Cancer, 73: 294-300, 1996.
19. Bringuier, P. P., Tamimi, E., Schuuring, E., and Schalken, J. Expression of cyclin D1 and EMS1 in bladder tumours: relationship with chromosome 11q13 amplification. Oncogene., 12: 1747-1753, 1996.
20. Nishida, N., Fukuda, Y., Komeda, T., Kita, R., Sando, T., Furukawa, M., Amenomori, M., Shibagaki, L. Nakao, K., Ikenaga, M., and Ishizaki, K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res., 54: 3107-3110, 1994.
21. Michalides, R., van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55: 975-978, 1995.
22. Masuda, M., Hirakawa, N., Nakashima, T., Kuratomi, Y., and Komiyama, S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer (Phila.), 78: 390-395, 1996.
23. Bellacosa, A., Almadori, G., Cavallo, S., Cadoni, G., Galli, J., Ferrandina, G., Scambia, G., and Neri, G. Cyclin D1 gene Amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin. Cancer Res., 2: 175-180, 1997.
24. Betticher, D., Thatcher, N., Altermatt, H. J., Hoban, P., Ryder, W. D., and Heighway, J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene., 11: 1005-1011, 1995.
25. Hermanek, P., and Sobin, L. H. (eds). TNM Classification of Malignant Tumours, Ed. 4. Berlin: Union Internationale Contre le Cancer, Springer-Verlag, 1987.
26. Sambrook, J., Fritsch, E. F., and Maniatis, T. (eds.). Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
27. Davidson, B. J., Lydiatt, W. M., Abate, M. P., Schantz, S. P., and Chaganti, R. S. K. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Head Neck J. Sci. Spec. Head Neck, 18: 512-521, 1996.
28. Fortin, A., Guerry, M., Guerry, R., Talbot, M., Parise, O., Scwaab, G., Bosq, J., Bourhis, J., Salvatori, P., Janot, F., and Busson, P. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence. Clin. Cancer Res., 3: 1609-1614, 1997.
29. Pines, J. Cyclins and their associated cyclin-dependent kinases in the human cell cycle. Biochem. Soc. Trans., 21: 921-925, 1993.
30. Nisho, M., Koshikawa, T., Yatabe, Y., Kuroishi, T., Suyama, M., Nagatake, M., Sugiura, T., Airiyoshi, Y., Mitsudomi, T., Takahashi, T., and Takahashi, T. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin. Cancer Res., 3: 1051-1058. 1997.
31. Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., and Sherr, C. J. Genes Dev., 7: 1559-1571, 1993.
32. Musgrove, E. A., Lee, C. S. L., Buckley, M. F., and Sutherland, R. L. Cyclin D1 induction in breast cancer cells shorten G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA, 91: 8022-8026, 1994.
33. Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., and Weinberg, R. A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA, 91: 709-713, 1994.
34. Lovec, H., Sewing, A., Lucibello, F. C., Muller, R., and Moroy, T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9: 323-326, 1994.
35. Kranenburg, O., van der Eb, A., and Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J., 15: 46-54, 1996.
36. Kotelnikov, V. M., Coon, J. S., IV, Mundle, S., Kelanic, S., LaFollette, S., Taylor, I. V. S., Hutchinson, J., Panje, W., Caldarelli, D. D., and Preisler, H. D. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin. Cancer Res., 3: 95-101, 1997.
37. Dulic, V., Drullinger, L. F., Lees, E., Reed, S. I., and Stein, G. H. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA, 90: 11034-11038, 1993.
38. Lucibello, F. C., Sewing, A., Brusselbach, S., Burger, C., and Muller, R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci., 105: 123-133, 1993.
39. Sawa, H., Ohshima, A., Ukita, H., Murakami, H., Chiba, Y., Kamanda, H., Hara, M., and Saito, I. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene, 16: 1701-1712, 1998.